Platinum-containing regimens for triple-negative metastatic breast cancer-Reference-Cited by-同舟云学术

Platinum-containing regimens for triple-negative metastatic breast cancer

Published:2020-10-21 Issue:12 Volume:2020 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Egger Sam J¹,Chan Matthew Ming Ki²,Luo Qingwei¹,Wilcken Nicholas³⁴

Affiliation:

1. Cancer Research Division; Cancer Council NSW; Sydney Australia

2. Department of Medical Oncology, Central Coast Cancer Centre; Gosford Hospital; Gosford Australia

3. Medical Oncology; Crown Princess Mary Cancer Centre; Westmead Australia

4. Sydney Medical School; The University of Sydney; Sydney Australia

Publisher

Wiley

Subject

Pharmacology (medical)

Reference80 articles.

1. Bhattacharyya GS Basu S Agarwal V Malhotra H Pareekh PM Babu KG 41LBA Single institute phase II study of weekly cisplatinum and metronomic dosing of endoxan and methotrexate in second line metastatic breast cancer triple-negative European Journal of Cancer Supplements 2009 18 19

2. TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer;Carey;Journal of Clinical Oncology,2012

3. Cetuximab + / - carboplatin for estrogen receptor-negative, progesterone receptor-negative metastatic breast cancer clinicaltrials.gov/show/NCT00232505

4. Docetaxel-cisplatin might be superior to docetaxel-capecitabine in the first-line treatment of metastatic triple-negative breast cancer;Fan;Annals of Oncology,2013

5. Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic breast cancer: randomized phase II study;Han;Annals of Oncology,2017

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SZC010 suppresses breast cancer development by regulating the PI3K/Akt/NF-κB signaling pathway;Chinese Clinical Oncology;2024-06

2. Chlorin Conjugates in Photodynamic Chemotherapy for Triple-Negative Breast Cancer;Pharmaceuticals;2024-04-30

3. Efficacy and Safety of First-line Carboplatin-paclitaxel and Carboplatin-gemcitabine in Patients With Advanced Triple-negative Breast Cancer: A Monocentric, Retrospective Comparison;Clinical Breast Cancer;2023-04

4. Patient-Derived Breast Cancer Bone Metastasis In Vitro Model Using Bone-Mimetic Nanoclay Scaffolds;Journal of Tissue Engineering and Regenerative Medicine;2023-03-11

5. Multiple Bayesian network meta-analyses to establish therapeutic algorithms for metastatic triple negative breast cancer;Cancer Treatment Reviews;2022-12